Resultats de la cerca - Erin R. Rudzinski
- Mostrar 1 - 20 resultats de 30
- Anar a la pàgina següent
-
1
Thyroid Cancer in the Pediatric Population per Vera Paulson, Erin R. Rudzinski, Douglas S. Hawkins
Publicat 2019Revisão -
2
-
3
-
4
-
5
-
6
-
7
The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group per Erin R. Rudzinski, James R. Anderson, Douglas S. Hawkins, Stephen X. Skapek, David M. Parham, Lisa A. Teot
Publicat 2015Artigo -
8
-
9
Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors per Kyle L. MacQuarrie, Zizhen Yao, Abraham Fong, Scott J. Diede, Erin R. Rudzinski, Douglas S. Hawkins, Stephen J. Tapscott
Publicat 2012Artigo -
10
<i>PAX-FOXO1</i>fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report per Stephen X. Skapek, James R. Anderson, Frederic G. Barr, Julia A. Bridge, Julie M. Gastier‐Foster, David M. Parham, Erin R. Rudzinski, Timothy J. Triche, Douglas S. Hawkins
Publicat 2013Artigo -
11
Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials per Sapna Oberoi, Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger, Kiran A Kumar, Kenneth Wong, Sarah S. Donaldson, Lisa A. Teot, Erin R. Rudzinski, Rajkumar Venkatramani
Publicat 2025Artigo -
12
Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma per Erin R. Rudzinski, Lisa A. Teot, James R. Anderson, Julie Moore, Julia A. Bridge, Frederic G. Barr, Julie M. Gastier‐Foster, Stephen X. Skapek, Douglas S. Hawkins, David M. Parham
Publicat 2013Artigo -
13
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low‐Risk Clinical Features: A Report From the Children's Oncology Group per Michael Arnold, James R. Anderson, Julie M. Gastier‐Foster, Frederic G. Barr, Stephen X. Skapek, Douglas S. Hawkins, R. Beverly Raney, David M. Parham, Lisa A. Teot, Erin R. Rudzinski, David Walterhouse
Publicat 2016Artigo -
14
Myogenin, AP2β, NOS-1, and HMGA2 Are Surrogate Markers of Fusion Status in Rhabdomyosarcoma per Erin R. Rudzinski, James R. Anderson, Elizabeth Lyden, Julia A. Bridge, Frederic G. Barr, Julie M. Gastier‐Foster, Karen M. Bachmeyer, Stephen X. Skapek, Douglas S. Hawkins, Lisa A. Teot, David M. Parham
Publicat 2014Artigo -
15
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Onco... per Emily Hibbitts, Yueh‐Yun Chi, Douglas S. Hawkins, Frederic G. Barr, Julie A. Bradley, Roshni Dasgupta, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Sheri L. Spunt, Stephen X. Skapek, Suzanne L. Wolden, Carola A.S. Arndt
Publicat 2019Artigo -
16
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from... per Abha A. Gupta, Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden, Barry Shulkin, Amira Qumseya, Jonathan C Routh, Tamara MacDonald, Shari L. Feinberg, Brian Crompton, Erin R. Rudzinski, Michael Arnold, Raj Venkatramani
Publicat 2024Artigo -
17
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma per Alyssa J. Penning, Alyaa Al‐Ibraheemi, Michael Michal, Brandon T. Larsen, Soo‐Jin Cho, Christina M. Lockwood, Vera Paulson, Yajuan J. Liu, Lukáš Plank, Karen Fritchie, Carol Beadling, Tanaya Neff, Christopher L. Corless, Erin R. Rudzinski, Jessica L. Davis
Publicat 2021Artigo -
18
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group per Erin R. Rudzinski, James R. Anderson, Yueh‐Yun Chi, Julie M. Gastier‐Foster, Caroline Astbury, Frederic G. Barr, Stephen X. Skapek, Douglas S. Hawkins, Brenda J. Weigel, Alberto S. Pappo, William H. Meyer, Michael Arnold, Lisa A. Teot, David M. Parham
Publicat 2017Artigo -
19
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib per James Chih‐Hsin Yang, Marcia S. Brose, Gilberto de Castro, Edward S. Kim, Ulrik Lassen, Serge Leyvraz, Alberto S. Pappo, Fernando López‐Ríos, John A. Reeves, Marc Fellous, Frédérique Penault‐Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan C. Trent
Publicat 2022Artigo -
20
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group per Jacquelyn Crane, Wei Xue, Amira Qumseya, Zhengya Gao, Carola A.S. Arndt, Sarah S. Donaldson, Douglas J. Harrison, Douglas S. Hawkins, Corinne M. Linardic, Leo Mascarenhas, William H. Meyer, David A. Rodeberg, Erin R. Rudzinski, Barry L. Shulkin, David Walterhouse, Rajkumar Venkatramani, Aaron R. Weiss
Publicat 2022Revisão
Eines de cerca:
Matèries relacionades
Medicine
Pathology
Internal medicine
Sarcoma
Oncology
Rhabdomyosarcoma
Biology
Cancer
Gene
Genetics
Cancer research
Receptor
Neurotrophin
Trk receptor
Clinical trial
Fusion gene
Surgery
Biochemistry
Embryonal rhabdomyosarcoma
Environmental health
Immunohistochemistry
Pediatrics
Population
Alveolar rhabdomyosarcoma
Artificial intelligence
Bioinformatics
Chemotherapy
Clinical endpoint
Cog
Computer science